C83.53
Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Lymphoblastic lymphoma is a rare and aggressive type of non-Hodgkin lymphoma that originates from lymphoid tissue. When it involves intra-abdominal lymph nodes, it can cause significant health problems due to rapid growth and potential spread. This condition primarily affects young adults but can occur at any age. Recognizing symptoms and understanding treatment options are crucial for effective management of this lymphoma subtype.
Causes & Symptoms
Clinical Causes: Genetic mutations within lymphoid cells that lead to uncontrolled proliferation Infections, such as Epstein-Barr virus (EBV), which have been linked to the development of certain lymphomas Immune system deficiencies or suppression, whether congenital or acquired Environmental factors or exposure to certain chemicals or radiation, although these are less well-defined History of other lymphoproliferative disorders or prior cancer treatments
Key Symptoms: Swelling or a palpable mass in the abdomen due to enlarged intra-abdominal lymph nodes Abdominal pain or discomfort Unintended weight loss and fatigue Night sweats Fever that persists without an apparent cause Gastrointestinal symptoms, such as nausea, vomiting, or changes in bowel habits Generalized symptoms like malaise or weakness
Diagnostic & Treatment
Diagnosis Path: The diagnosis of lymphoblastic lymphoma involving intra-abdominal lymph nodes typically involves a combination of clinical evaluation and diagnostic tests, including:
Treatment Protocols: Treating lymphoblastic lymphoma typically involves intensive combination therapy, often similar to treatments used for acute lymphoblastic leukemia (ALL). Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is C83.53 a billable ICD-10 code?
Yes, C83.53 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.53?
Clinical documentation must specify the nature of Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference